isvav_result

publication_year

occurrences__organization__code

solver__id__sc2

result_type__code

Type of result according to the RIV classification. Czech version is available <a href="https://www.vyzkum.cz/FrontClanek.aspx?idsekce=1395" target="_blank" >here</a>.

language__code

Jazyk výsledku udáva původní jazyk, ve kterém byl daný výsledek vytvořen. Kompletní seznam jazyků ve kterém je možno výsledek do RIV předložit je <a href="https://www.vyzkum.cz/FrontClanek.aspx?idsekce=1397" target="_blank" >zde</a>.

cep__code

ford__code

_group_id67

occurrences__funder__code

Data supplier is the R&D aid provider who supported this result.

project__programme__code

x_range_count_solvers

project__id

What are you looking for?

Quick search

Smart search

Filters

Mechanical Circulatory Support in Refractory Vasodilatory Septic Shock: A Randomized Controlled Porcine Study

Efficacy and safety of carfilzomib regimens in multiple myeloma patients relapsing after autologous stem cell transplant: ASPIRE and ENDEAVOR outcomes

Second relapse of pediatric patients with acute myeloid leukemia: A report on current treatment strategies and outcome of the AML-BFM study group

Survival following relapse in children with acute myeloid leukemia: A report from aml-bfm and cog

International reference analysis of outcomes in adults with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia

Complications of total laryngectomy in the era of chemoradiation

Dacetuzumab plus rituximab, ifosfamide, carboplatin and etoposide as salvage therapy for patients with diffuse large B-cell lymphoma relapsing after rituximab, cyclophosphamide, doxorubicin

Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group

Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis